Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells

Cancer Letters

Volumn 213, Issue 2, 2004, Pages 203-212

  Kim, Jung Whan ^a   Wong, Christopher W ^a   Goldsmith, Jeffery D ^a   Song, C ^a   Fu, Weili ^a   Allion, Mary Beth ^a   Herlyn, Meenhard ^a   Al Mehdi, Abu B ^a   Muschel, Ruth J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; BAD; GFP, green fluorescent protein; Melanoma; Pulmonary vasculature

Indexed keywords

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN BAD;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSFECTION; ISOLATED LUNG; LUNG BLOOD VESSEL; MELANOMA CELL; METASTASIS; MITOCHONDRION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL SURVIVAL; FIBROBLASTS; HUMANS; LUNG; LUNG NEOPLASMS; MELANOMA; MICE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RATS; SKIN NEOPLASMS; TIME FACTORS;

EID: 4344589420     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.042     Document Type: Article

References (43)

1. Wong C.W., Lee A., Shientag L., Yu J., Dong Y., Kao G., et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61:2001;333-338
2. Khanna C., Wan X., Bose S., Cassaday R., Olomu O., Mendoza A., et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10:2004;182-186
3. Juhasz I., Albelda S.M., Elder D.E., Murphy G.F., Adachi K., Herlyn D., et al. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am. J. Pathol. 143:1993;528-537
4. Graeven U., Herlyn M. In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression. J. Immunother. 12:1992;199-202
5. Hsu M.-Y., Elder D.E., Herlyn M. Melanoma: the Wistar Melanoma (WM) Cell Lines. Master J.R.W., Palsson B. Human Cell Culture. vol. 1:1999;259-274 Kluwer Academic Publishers, Great Britain
6. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241
7. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death, Cell. 80:1995;285-291
8. Hsu S.Y., Kaipia A., Zhu L., Hsueh A.J. Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Mol. Endocrinol. 11:1997;1858-1867
9. Kelekar A., Chang B.S., Harlan J.E., Fesik S.W., Thompson C.B. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol. 17:1997;7040-7046
10. Zha J., Harada H., Osipov K., Jockel J., Waksman G., Korsmeyer S.J. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J. Biol. Chem. 272:1997;24101-24104
11. Reed J.C. Apoptosis and cancer: strategies for integrating programmed cell death. Semin. Hematol. 37:2000;9-16
12. Adams J.M., Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:2001;61-66
13. Green D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:2000;1-4
14. Jan M.S., Liu H.S., Lin Y.S. Bad overexpression sensitizes NIH/3T3 cells to undergo apoptosis which involves caspase activation and ERK inactivation. Biochem. Biophys. Res. Commun. 264:1999;724-729
15. Wang H.G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:1999;339-343
16. Li X., Marani M., Mannucci R., Kinsey B., Andriani F., Nicoletti I., et al. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res. 61:2001;1699-1706
17. Condorelli F., Salomoni P., Cotteret S., Cesi V., Srinivasula S.M., Alnemri E.S., Calabretta B. Caspase cleavage enhances the apoptosis-inducing effects of BAD. Mol. Cell. Biol. 21:2001;3025-3036
18. Bernhard E.J., Gruber S.B., Muschel R.J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA. 91:1994;4293-4429
19. Al-Mehdi A.B., Zhao G., Dodia C., Tozawa K., Costa K., Muzykantov V., et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ. Res. 83:1998;730-737
20. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., Muschel R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6:2000;100-102
21. Fidler I.J. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl. Cancer Inst. 45:1970;773-782
22. Fidler I.J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35:1975;218-224
23. Price J.E., Aukerman S.L., Fidler I.J. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res. 46:1986;5172-5178
24. Weiss L. Metastatic inefficiency. Adv. Cancer Res. 54:1990;159-211
25. Nikiforov M.A., Kwek S.S., Mehta R., Artwohl J.E., Lowe S.W., Gupta T.D., et al. Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence. Oncogene. 15:1997;3007-3012
26. Takaoka A., Adachi M., Okuda H., Sato S., Yawata A., Hinoda Y., et al. Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene. 14:1997;2971-2977
27. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv. Cancer Res. 76:1999;1-20
28. Zhu Z., Sanchez-Sweatman O., Huang X., Wiltrout R., Khokha R., Zhao Q., Gorelik E. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res. 61:2001;1707-1716
29. Baldi A., Dragonetti E., Battista T., Groeger A.M., Esposito V., Baldi G., Santini D. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients. Anticancer Res. 20:2000;3923-3928
30. Brochez L., Naeyaert J.M. Serological markers for melanoma. Br. J. Dermatol. 143:2000;256-268
31. Brownbridge G.G., Gold J., Edward M., MacKie R.M. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled- polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma. Br. J. Dermatol. 144:2001;279-287
32. Mehes G., Witt A., Kubista E., Ambros P.F. Circulating breast cancer cells are frequently apoptotic. Am. J. Pathol. 159:2001;17-20
33. Glaves D., Huben R.P., Weiss L. Haematogenous dissemination of cells from human renal adenocarcinomas. Br. J. Cancer. 57:1988;32-35
34. Tarin D., Price J.E., Kettlewell M.G., Souter R.G., Vass A.C., Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 44:1984;3584-3592
35. Owen-Schaub L.B., van Golen K.L., Hill L.L., Price J.E. Fas and Fas ligand interactions suppress melanoma lung metastasis. J. Exp. Med. 188:1998;1717-1723
36. Owen-Schaub L. Soluble fas and cancer. Clin. Cancer Res. 7:2001;1108-1109
37. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 409:2001;207-211
38. Raisova M., Bektas M., Wieder T., Daniel P., Eberle J., Orfanos C.E., Geilen C.C. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. Fed. Eur. Biochem. Sci. Lett. 473:2000;27-32
39. Grossman D., Kim P.J., Schechner J.S., Altieri D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA. 98:2001;635-640
40. Hsu M.Y., Shih D.T., Meier F.E., Van Belle P., Hsu J.Y., Elder D.E., et al. Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am. J. Pathol. 153:1998;1435-1442
41. Li G., Satyamoorthy K., Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 61:2001;3819-3825
42. Inbal B., Cohen O., Polak-Charcon S., Kopolovic J., Vadai E., Eisenbach L., et al. links the control of apoptosis to metastasis. Nature. 390:1997;180-184
43. Yu Q., Toole B.P., Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J. Exp. Med. 186:1997;1985-1996